NO148491C - Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 21-salisylsyre- og 21-acetylsalicylsyreestre av steroider av pregnanserien - Google Patents
Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 21-salisylsyre- og 21-acetylsalicylsyreestre av steroider av pregnanserienInfo
- Publication number
- NO148491C NO148491C NO774525A NO774525A NO148491C NO 148491 C NO148491 C NO 148491C NO 774525 A NO774525 A NO 774525A NO 774525 A NO774525 A NO 774525A NO 148491 C NO148491 C NO 148491C
- Authority
- NO
- Norway
- Prior art keywords
- inflammatorally
- pregnancy
- steroids
- preparation
- effective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB54510/76A GB1593978A (en) | 1976-12-31 | 1976-12-31 | Anti-inflammatory steroids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO774525L NO774525L (no) | 1978-07-03 |
| NO148491B NO148491B (no) | 1983-07-11 |
| NO148491C true NO148491C (no) | 1983-10-19 |
Family
ID=10471258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO774525A NO148491C (no) | 1976-12-31 | 1977-12-30 | Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 21-salisylsyre- og 21-acetylsalicylsyreestre av steroider av pregnanserien |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS53144561A (no) |
| BE (1) | BE862507A (no) |
| CH (1) | CH633301A5 (no) |
| DK (1) | DK155673C (no) |
| FI (1) | FI63422C (no) |
| FR (1) | FR2376160A1 (no) |
| GB (1) | GB1593978A (no) |
| NL (1) | NL7714482A (no) |
| NO (1) | NO148491C (no) |
| SE (1) | SE430607B (no) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1440063A (en) * | 1972-08-11 | 1976-06-23 | Glaxo Lab Ltd | 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids |
-
1976
- 1976-12-31 GB GB54510/76A patent/GB1593978A/en not_active Expired
-
1977
- 1977-12-27 FI FI773929A patent/FI63422C/fi not_active IP Right Cessation
- 1977-12-28 NL NL7714482A patent/NL7714482A/xx not_active Application Discontinuation
- 1977-12-28 JP JP15754377A patent/JPS53144561A/ja active Granted
- 1977-12-28 DK DK581677A patent/DK155673C/da not_active IP Right Cessation
- 1977-12-30 CH CH1632977A patent/CH633301A5/de not_active IP Right Cessation
- 1977-12-30 BE BE183990A patent/BE862507A/xx not_active IP Right Cessation
- 1977-12-30 SE SE7714976A patent/SE430607B/sv unknown
- 1977-12-30 FR FR7739817A patent/FR2376160A1/fr active Granted
- 1977-12-30 NO NO774525A patent/NO148491C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2376160A1 (fr) | 1978-07-28 |
| JPS53144561A (en) | 1978-12-15 |
| DK581677A (da) | 1978-07-01 |
| DK155673C (da) | 1989-09-04 |
| NO774525L (no) | 1978-07-03 |
| NO148491B (no) | 1983-07-11 |
| SE7714976L (sv) | 1978-07-02 |
| NL7714482A (nl) | 1978-07-04 |
| FI63422B (fi) | 1983-02-28 |
| JPS6220197B2 (no) | 1987-05-06 |
| GB1593978A (en) | 1981-07-22 |
| SE430607B (sv) | 1983-11-28 |
| CH633301A5 (en) | 1982-11-30 |
| DK155673B (da) | 1989-05-01 |
| BE862507A (fr) | 1978-04-14 |
| FI773929A (fi) | 1978-07-01 |
| FI63422C (fi) | 1983-06-10 |
| FR2376160B1 (no) | 1980-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE432420B (sv) | Forfarande for framstellning av terapeutiskt verksamma hydroxamsyror | |
| NO151622C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive carboxyalkyldipeptider | |
| NO148925C (no) | Analogifremgangsmaate til fremstilling av 5-metyl-isoksazol-4-karboksylsyre-(4-trifluormetyl)-anilid med antiflogistisk og antireumatisk virkning | |
| MX5502E (es) | Procedimiento para la preparacion de eteres y esteres de oximas | |
| NO812197L (no) | Fremgangsmaate ved fremstilling av 10-alkynylsteroider | |
| NO771578L (no) | Fremgangsmaate for fremstilling av di-n-propyleddiksyre | |
| NO147953C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider | |
| SE7714349L (sv) | Forfarande for framstellning av hydroxamsyror | |
| NO148069C (no) | Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenylalanin-methylester | |
| NO780777L (no) | Fremgangsmaate ved fremstilling av 1-azaxanthon-3-carboxylsyrer | |
| SE7901000L (sv) | Forfarande for framstellning av terpenoidestrar av steroider | |
| NO792651L (no) | Fremgangsmaate for fremstilling av spesielle steroider | |
| NO152605C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-pyridyl- og 2-pyrimidylaminobenzoesyrer | |
| SE421787B (sv) | Forfarande for framstellning av kvadratsyra | |
| NO773622L (no) | Fremgangsmaate til fremstilling av tereftalsyre | |
| NO148491C (no) | Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 21-salisylsyre- og 21-acetylsalicylsyreestre av steroider av pregnanserien | |
| NO141716C (no) | Fremgangsmaate for fremstilling av tiokarbaminsyreestere | |
| NO143346C (no) | Fremgangsmaate ved fremstilling av thymosin alfa1 | |
| NO772889L (no) | Fremgangsmaate ved fremstilling av dietnaeringsmiddel | |
| SE434743B (sv) | Forfarande for framstellning av (2-pyrimidinyl-tio)-alkansyraamider | |
| SE7804856L (sv) | Forfarande vid framstellning av sampolymerisat av maleinsyraanhydrid och vinyltrialkoxisilaner | |
| SE430416B (sv) | Forfarande for framstellning av alkoxisubstituerade tiofenkarboxylsyror och estrar derav | |
| NO143503C (no) | Analogifremgangsmaate ved fremstilling av 13-alkyl-d-homo-gona-diener med hormonvirkning | |
| NO147303C (no) | Fremgangsmaate ved fremstilling og utvinning av halogenacetamider | |
| SE7812936L (sv) | Forfarande for framstellning av 2-acetamidokanelsyra |